(S (NP (NP (VBN Automated) (JJ computer-aided) (NN detection)) (PRN (-LRB- -LRB-) (NP (NNP CADe)) (-RRB- -RRB-)) (PP (IN in) (NP (JJ medical) (NN imaging)))) (VP (VBZ has) (VP (VBN been) (NP (DT an) (JJ important) (NN tool)) (PP (IN in) (NP (JJ clinical) (NN practice) (CC and) (NN research))))) (. .))
(S (NP (JJ State-of-the-art) (NNS methods)) (ADVP (RB often)) (VP (VBP show) (NP (JJ high) (NNS sensitivities)) (PP (CC but) (PP (IN at) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (NP (JJ high) (NNS false-positives)) (PRN (-LRB- -LRB-) (NP (NNP FP)) (-RRB- -RRB-)) (PP (IN per) (NP (NN patient) (NNS rates))))))))) (. .))
(S (PP (IN By) (S (VP (VBG leveraging) (NP (VBG existing) (NNP CAD) (NNS systems))))) (, ,) (NP (NP (NNS coordinates)) (PP (IN of) (NP (NP (NP (NP (NNS regions) (CC or) (NNS volumes)) (PP (IN of) (NP (NN interest)))) (PRN (-LRB- -LRB-) (NP (NNP ROI) (CC or) (NNP VOI)) (-RRB- -RRB-))) (PP (IN for) (NP (NN lesion) (NNS candidates)))))) (VP (VP (VBP are) (VP (VBN generated) (PP (IN in) (NP (DT this) (NN step))))) (CC and) (VP (NN function) (PP (IN as) (NP (NP (NN input)) (PP (IN for) (NP (NP (DT a) (JJ second) (NN tier)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (PRP$ our) (NN focus)) (PP (IN in) (NP (DT this) (NN study))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (JJ second) (NN stage))) (, ,) (NP (PRP we)) (VP (VBP generate) (NP (UCP ($ $) (NNP N) ($ $) (CD 2D) (PRN (-LRB- -LRB-) (ADJP (JJ two-dimensional)) (-RRB- -RRB-)) (CC or) (CD 2.5D)) (NNS views)) (PP (IN via) (NP (NP (VBG sampling)) (PP (IN through) (NP (NP (JJ scale) (NNS transformations)) (, ,) (NP (JJ random) (NNS translations)) (CC and) (NP (NP (NNS rotations)) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NP (DT each) (NNP ROI) (POS 's)) (NN centroid) (NNS coordinates))))))))))) (. .))
(S (NP (DT These) (JJ random) (NNS views)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB train) (NP (JJ deep) (JJ convolutional) (JJ neural) (NN network) (PRN (-LRB- -LRB-) (NNP ConvNet) (-RRB- -RRB-)) (NNS classifiers))))))) (. .))
(S (PP (IN In) (NP (VBG testing))) (, ,) (NP (DT the) (JJ trained) (NNS ConvNets)) (VP (VBP are) (VP (VBN employed) (S (VP (TO to) (VP (VB assign) (NP (NP (NN class) (PRN (-LRB- -LRB-) (JJ e.g.) (, ,) (NN lesion) (, ,) (NN pathology) (-RRB- -RRB-)) (NNS probabilities)) (PP (IN for) (NP (NP (NP (DT a) (JJ new) (NN set)) (PP (IN of) (NP (ADJP ($ $) (NNP N) ($ $)) (JJ random) (NNS views)))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB then)) (VP (VBN averaged) (PP (IN at) (NP (DT each) (NNP ROI))) (S (VP (TO to) (VP (VB compute) (NP (DT a) (JJ final) (NN per-candidate) (NN classification) (NN probability))))))))))))))))) (. .))
(S (NP (DT This) (JJ second) (NN tier)) (VP (NNS behaves) (PP (IN as) (NP (DT a) (ADJP (RB highly) (JJ selective)) (NN process))) (S (VP (TO to) (VP (VB reject) (NP (JJ difficult) (JJ false) (NNS positives)) (SBAR (IN while) (S (VP (VBG preserving) (NP (JJ high) (NNS sensitivities))))))))) (. .))
(S (NP (DT The) (NNS methods)) (VP (VBP are) (VP (VBN evaluated) (PP (IN on) (NP (NP (NP (CD three) (JJ different) (NNS data) (NNS sets)) (PP (IN with) (NP (NP (JJ different) (NNS numbers)) (PP (IN of) (NP (NNS patients)))))) (: :) (NP (NP (NP (CD 59) (NNS patients)) (PP (IN for) (NP (JJ sclerotic) (NNS metastases) (NN detection)))) (, ,) (NP (NP (CD 176) (NNS patients)) (PP (IN for) (NP (JJ lymph) (JJ node) (NN detection)))) (, ,) (CC and) (NP (NP (CD 1,186) (NNS patients)) (PP (IN for) (NP (JJ colonic) (NN polyp) (NN detection))))))))) (. .))
(S (NP (JJ Experimental) (NNS results)) (VP (VBP show) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NNS ConvNets))) (S (VP (TO to) (VP (VP (VB generalize) (ADVP (RB well)) (PP (TO to) (NP (JJ different) (JJ medical) (NN imaging) (NNP CADe) (NNS applications)))) (CC and) (VP (NN scale) (ADVP (RB elegantly)) (PP (TO to) (NP (JJ various) (NNS data) (NNS sets))))))))) (. .))
(S (NP (PRP$ Our) (VBN proposed) (NNS methods)) (VP (VB improve) (NP (NNP CADe) (NN performance)) (ADVP (RB markedly)) (PP (IN in) (NP (DT all) (NNS cases)))) (. .))
(S (NP (NNP CADe) (NNS sensitivities)) (VP (VP (VBN improved) (PP (PP (IN from) (NP (CD 57) (NN %))) (PP (TO to) (NP (CD 70) (NN %))))) (, ,) (PP (PP (IN from) (NP (CD 43) (NN %))) (PP (TO to) (NP (CD 77) (NN %)))) (CC and) (VP (IN from) (NP (CD 58) (NN %)) (PP (TO to) (NP (CD 75) (NN %)))) (PP (IN at) (NP (NP (CD 3) (NNP FPs)) (PP (FW per) (NP (NN patient))))) (PP (IN for) (NP (NP (NP (JJ sclerotic) (NNS metastases)) (, ,) (NP (NN lymph) (NNS nodes)) (CC and) (NP (JJ colonic) (NNS polyps))) (, ,) (ADVP (RB respectively))))) (. .))
